Selvita S.A. (WSE:SLV)
Poland · Delayed Price · Currency is PLN 33.70
+0.70 (2.12%)
Apr 16, 2026, 5:00 PM CET
Selvita Revenue
In the year 2025, Selvita had annual revenue of 371.13M PLN with 7.34% growth. Selvita had revenue of 95.41M in the quarter ending December 31, 2025, a decrease of -2.82%.
Revenue
371.13M
Revenue Growth
+7.34%
P/S Ratio
1.67
Revenue / Employee
383.00K
Employees
969
Market Cap
618.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 371.13M | 25.37M | 7.34% |
| Dec 31, 2024 | 345.76M | -6.09M | -1.73% |
| Dec 31, 2023 | 351.85M | -12.70M | -3.48% |
| Dec 31, 2022 | 364.55M | 48.83M | 15.47% |
| Dec 31, 2021 | 315.73M | 173.80M | 122.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.64B |
| Diagnostyka | 2.30B |
| Centrum Medyczne ENEL-MED | 820.59M |
| Synektik Spólka Akcyjna | 706.45M |
| Mercator Medical | 585.57M |
| Celon Pharma | 225.60M |
| Ryvu Therapeutics | 87.70M |
| Captor Therapeutics Spolka Akcyjna | 7.57M |